Management of T2DM Flashcards
what is the main treatment outline
- metformin
- metformin plus non injectable
- metformin plus plus GLP1 or insulin
- 4
action of metformin
suppress hepatic gluconeogensis, reducing glucose output from liver and increase glucose uptake
name of a sulphonylurea
gliclazide
benefits of metformin
Moderate efficacy, weight reduction, low hypo risk, CV benefit, extensive experience
benefits of sulphonylurea
High efficacy, extensive experience experience
side effects of metformin
GI side effects, No if eGFR<30, small risk of lactic acidosis
sulphonylurea action
•Close potassium channels on beta cells, stimulating release of stored insulin
side effects of sulphonylurea
No CV benefit, weight gain, high hypo risk, caution in CKD
Less effective over time because like squeezing insulin from a sponge, not effective in type 1 as nothing there in first place
name a DPP4 inhibitor
linagliptin
DPP4 inhibitor benefits
Low/Moderate efficacy, low hypo risk, few adverse events
DPP4 inhibits action
•Inhibit DPP-4 and enhance effects of endogenous incretins (eg. GLP-1)
SGLT 2 inhibitor action
•Inhibit SGLT2 in the proximal convoluted tubule of the kidney
benefits of SGLT 2
Moderate efficacy, CV benefit (BP + HF), renal benefit (CANA), Weight loss, low hypo risk, reduced CV events
side effects of SGLT 2
Risk of GU infections, Small risk of hypovolaemia/DKA, do not start if eGFR<60
how do thiazolidinediones work
PPAR gamma-receptor agonists
•Increase sensitivity of fat, muscles, and liver to endogenous and exogenous insulin
Rarely used